Understanding Ricin's Active Site Changes
Author Information
Author(s): Carra John H, McHugh Colleen A, Mulligan Sheila, Machiesky LeeAnn M, Soares Alexei S, Millard Charles B
Primary Institution: United States Army Medical Research Institute of Infectious Diseases
Hypothesis
Can fragment-based approaches identify minimal bonding interactions that induce conformational changes in the ricin A-chain active site?
Conclusion
Amide ligands can bind weakly but specifically to the ricin active site, causing significant shifts in critical active site residues.
Supporting Evidence
- The smallest ligand stabilizing an open conformer of the RTA active site was an amide group.
- Fluorescence changes provided a useful probe for examining ligand binding.
- Binding of urea was specific to the depurination locus of the ricin A-chain.
Takeaway
This study found that small molecules can change the shape of a toxic protein called ricin, which might help in designing new medicines to fight it.
Methodology
The study used a fragment-based approach to identify bonding interactions and measured fluorescence changes to assess binding.
Limitations
The binding interactions were weak and specific to the active site, which may limit the generalizability of the findings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website